Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Inventory (2024 - 2025)

Historic Inventory for X4 Pharmaceuticals (XFOR) over the last 2 years, with Q3 2025 value amounting to $4.1 million.

  • X4 Pharmaceuticals' Inventory rose 6687.12% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 6687.12%. This contributed to the annual value of $2.8 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, X4 Pharmaceuticals' Inventory stood at $4.1 million, which was up 6687.12% from $3.2 million recorded in Q2 2025.
  • X4 Pharmaceuticals' 5-year Inventory high stood at $4.1 million for Q3 2025, and its period low was $831000.0 during Q2 2024.